Clinical Trials Browser

Not yet recruiting × Lymphoma, Non-Hodgkin × Lisaftoclax × Clear all

NCT07159906 2025-09-08

Homoharringtonine, BCL-2 Inhibitor, Rituximab, and Prednisone in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Phase 1/2 Not yet recruiting

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse